Cancer Res Treat.  2022 Oct;54(4):1065-1073. 10.4143/crt.2021.835.

Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term Breast Cancer Survivors

• Tran TXM
• Jung SY
• Lee EG
• Cho H
• Kim NY
• Shim S
• Kim HY
• Kang D
• Cho J
• Lee E
• Chang YJ
• Cho H

• KMID: 2534185
• DOI: http://doi.org/10.4143/crt.2021.835

Abstract

Purpose
Fear of cancer recurrence (FCR) is a common psychological issue in breast cancer (BC) survivors during early survivorship but whether the same is true among long-term survivors has yet to be empirically evaluated. This study investigated FCR level, its associated factors, and impact on quality of life (QoL) in long-term BC survivors.
Materials and Methods
Participants included women diagnosed with BC between 2004 and 2010 at two tertiary hospitals. Survey was conducted in 2020. The study measured FCR with the Fear of Cancer Recurrence Inventory and other patient-reported outcomes, including depression and cancer-related QoL. Logistic regression was used to identify factors associated with FCR, and structural equation modeling was conducted to explore the impact of FCR on other outcomes.
Results
Of 333 participants, the mean age at diagnosis was 45.5, and 46% experienced FCR. Age at diagnosis ≤ 45 (adjusted odds ratio [aOR], 2.64; 95% confidence interval [CI], 1.51 to 4.60), shorter time since diagnosis (aOR, 1.75, 95% CI, 1.08 to 2.89), and having a history of recurrence (aOR, 2.56; 95% CI, 1.16 to 5.65) was associated with more FCR. FCR was significantly associated with an increased risk of depression (β=0.471, p < 0.001) and negatively impacted emotional functioning (β=–0.531, p < 0.001). In addition, a higher FCR level may impair overall health-related QoL in long-term BC survivors (β=–0.108, p=0.021).
Conclusion
Ten years after diagnosis, long-term BC survivors still experienced a high level of FCR. Further, the negative impact of FCR on QoL and increased depression risk require an FCR screening and appropriate interventions to enhance long-term BC survivors' QoL.

Keyword

Fear of cancer recurrence; Depression; Quality of life; Breast cancer survivor; Young breast cancer

Figure

• 

  Fig. 1 Correlations between FCRI and other factors. The brown color indicates the statistically significant negative associations. The green color indicates the statistically significant positive associations. The white color indicates non-significant associations. A darker color indicates stronger correlations. EQ-5D, EuroQol 5-Dimension Questionnaire Index; FCRI, Fear of Cancer Inventory; stage, stage at diagnosis; Time dx, time since diagnosis (in year).

• 

  Fig. 2 Path diagram of the SEM model for the associations between fear of cancer recurrence and other patient-reported outcomes. The structural model presents the effects of age at diagnosis, time since diagnosis, history of recurrence, fear of cancer recurrence, and other patient-reported outcomes. FCRI, Fear of Cancer Recurrence Inventory; QoL, quality of life; SEM, structural equation model. *p < 0.05, ***p < 0.001.

Reference

References

1. Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat. 2020; 52:335–50.

2. Simard S, Savard J, Ivers H. Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv. 2010; 4:361–71.

3. Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009; 27:6172–9.

4. Thewes B, Butow P, Bell ML, Beith J, Stuart-Harris R, Grossi M, et al. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer. 2012; 20:2651–9.

5. Harrison SE, Watson EK, Ward AM, Khan NF, Turner D, Adams E, et al. Primary health and supportive care needs of long-term cancer survivors: a questionnaire survey. J Clin Oncol. 2011; 29:2091–8.

6. Bloom JR, Petersen DM, Kang SH. Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology. 2007; 16:691–706.

7. Hong SJ, Shin NM, Jung S. A predictive model of fear of cancer recurrence for patients undergoing chemotherapy. Support Care Cancer. 2020; 28:4173–81.

8. Shin J, Goo A, Ko H, Kim JH, Lim SU, Lee HK, et al. Validation study for the Korean version of fear of cancer recurrence inventory. J Korean Med Sci. 2017; 32:1792–9.

9. Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2017. Sejong: Ministry of Health and Welfare;2019.

10. Lee ES, Lee MK, Kim SH, Ro JS, Kang HS, Kim SW, et al. Health-related quality of life in survivors with breast cancer 1 year after diagnosis compared with the general population: a prospective cohort study. Ann Surg. 2011; 253:101–8.

11. Mai TTX, Choi JH, Lee MK, Chang YJ, Jung SY, Cho H, et al. Prognostic value of post-diagnosis health-related quality of life for overall survival in breast cancer: findings from a 10-year prospective cohort in Korea. Cancer Res Treat. 2019; 51:1600–11.

12. Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009; 17:241–51.

13. Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv. 2015; 9:481–91.

14. Peng L, Huang W, Zhang W, Xu Y, Lu F, Zhong L, et al. Psychometric properties of the short form of the fear of cancer recurrence inventory (FCRI) in Chinese breast cancer survivors. Front Psychiatry. 2019; 10:537.

15. Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, et al. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004; 13:863–8.

16. Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health. 2009; 12:1187–93.

17. Rosseel Y. lavaan: an R package for structural equation modeling. J Stat Softw. 2012; 48:1–36.

18. Hooper D, Coughlan J, Mullen M. Structural equation modelling: guidelines for determining model fit. Electron J Bus Res Methods. 2008; 6:53–60.

19. Champagne A, Ivers H, Savard J. Utilization of health care services in cancer patients with elevated fear of cancer recurrence. Psychooncology. 2018; 27:1958–64.

20. Lebel S, Tomei C, Feldstain A, Beattie S, McCallum M. Does fear of cancer recurrence predict cancer survivors’ health care use? Support Care Cancer. 2013; 21:901–6.

21. Savard J, Ivers H. The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res. 2013; 74:354–60.

22. Fardell JE, Jones G, Smith AB, Lebel S, Thewes B, Costa D, et al. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence. Psychooncology. 2018; 27:492–9.

23. Vickberg SM. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003; 25:16–24.

24. Lane BE, Garland SN, Chalifour K, Eaton G, Lebel S, Galica J, et al. Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with cancer. J Cancer Surviv. 2019; 13:842–51.

25. Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat. 2009; 113:357–70.

26. Waljee JF, Hu ES, Ubel PA, Smith DM, Newman LA, Alderman AK. Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol. 2008; 26:3331–7.

27. Borreani C, Alfieri S, Farina L, Bianchi E, Corradini P. Fear of cancer recurrence in haematological cancer patients: exploring socio-demographic, psychological, existential and disease-related factors. Support Care Cancer. 2020; 28:5973–82.

28. Petzel MQ, Parker NH, Valentine AD, Simard S, Nogueras-Gonzalez GM, Lee JE, et al. Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumors. Ann Surg Oncol. 2012; 19:4078–84.

29. Butow PN, Turner J, Gilchrist J, Sharpe L, Smith AB, Fardell JE, et al. Randomized trial of ConquerFear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence. J Clin Oncol. 2017; 35:4066–77.

30. Murphy MJ, Newby JM, Butow P, Loughnan SA, Joubert AE, Kirsten L, et al. Randomised controlled trial of internet-delivered cognitive behaviour therapy for clinical depression and/or anxiety in cancer survivors (iCanADAPT Early). Psychooncology. 2020; 29:76–85.

31. Denlinger CS, Sanft T, Moslehi JJ, Overholser L, Armenian S, Baker KS, et al. NCCN guidelines insights: survivorship, version 2.2020. J Natl Compr Canc Netw. 2020; 18:1016–23.